TD Cowen initiated coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research note released on Tuesday morning, Marketbeat.com reports. The firm issued an outperform rating on the stock. APGE has been the topic of several other research reports. Guggenheim began coverage on shares of Apogee Therapeutics in a research report on […]
Jefferies Financial Group began coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $29.00 target price on the stock. Apogee Therapeutics Stock Performance Apogee Therapeutics stock opened at $21.95 on Tuesday. Apogee Therapeutics has a fifty-two week […]
Jefferies Financial Group began coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm issued a buy rating and a $29.00 price target on the stock. Apogee Therapeutics Stock Up 1.5 % Shares of APGE opened at $21.95 on Tuesday. Apogee Therapeutics […]
Apogee Therapeutics (NASDAQ:APGE) Coverage Initiated at Guggenheim kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Equities research analysts at TD Cowen initiated coverage on shares of Apogee Therapeutics (NASDAQ:APGE – Get Free Report) in a report released on Tuesday, Briefing.com reports. The firm set an “outperform” rating on the stock. A number of other research firms have also recently weighed in on APGE. Jefferies Financial Group started coverage on Apogee […]